EFFECTS OF PROTON PUMP INHIBITORS ON DENTAL EROSIONS CAUSED BY GASTROESOPHAGEAL REFLUX DISEASE

Size: px
Start display at page:

Download "EFFECTS OF PROTON PUMP INHIBITORS ON DENTAL EROSIONS CAUSED BY GASTROESOPHAGEAL REFLUX DISEASE"

Transcription

1 Odontology EFFECTS OF PROTON PUMP INHIBITORS ON DENTAL EROSIONS CAUSED BY GASTROESOPHAGEAL REFLUX DISEASE Andrei Vasile OLTEANU 1, Dana Elena MITRICĂ 2, Gheorghe Gh. BĂLAN 3, Carmen SAVIN 4, Adriana BĂLAN 4 1 M.D., PhD student, Gr. T.Popa UMPh of Iaşi, Faculty of Medicine 2 M.D., PhD, Gr. T.Popa UMPh of Iaşi, Faculty of Medicine 3 LL.B., M.D., PhD student, Gr. T.Popa UMPh of Iaşi, Faculty of Medicine 4 DMD, PhD, Gr. T.Popa UMPh of Iaşi, Faculty of Dental Medicine Corresponding author: balan.gheo@yahoo.com Abstract Background: Numerous studies worldwide have assessed the association between dental erosions or other related oral manifestations, and the gastroesophageal reflux disease (GERD). Nowadays, one of the main therapeutic resources of GERD is represented by proton pump inhibitors (PPIs). Adequate salivary secretions and flow are considered mandatory for the protection of both teeth and esophageal mucosa. The aim of the present study was to evaluate the possible correlation between GERD treatment options and subsequent control of oral manifestation, taking as premises that either PPIs or dietary and lifestyle changes may control oral patterns of GERD by acting on salivary secretions. Methods: 48 clinically diagnosed GERD adult patients with oral manifestations, mainly erosions, were included in the study, none of which showing alarming symptoms that would require further gastroenterologic examination. Oral examination evaluated the DMF (decayed, missing, filled) and OHI-S (Simplified Oral Hygiene) indices. Salivary flow was evaluated by the Saxon test. 25 patients were prescribed dietary and lifestyle measures and PPIs (omeprazole 20 mg), whereas 23 patients were managed only through dietary and lifestyle modifications. General assessment was performed at the time of diagnosis and 4 weeks afterwards. Results: No significant differences as to the DMF index, OHI-S index or Saxon test were found over the 4 weeks management between the groups. Conclusions: Oral manifestation of GERD may be caused by impaired salivary secretions and flow, otherwise no - positive or negative - effect could be secondary to PPI therapy. Accordingly, complex oral rehabilitation of GERD patients and collaboration between gastroenterologists and dentists should be promoted. Keywords: gastroesophageal reflux, dental erosion, oral manifestations, proton pump inhibitors, diet. 1. INTRODUCTION The common dietary habits of the 21 st century have made gastroesophageal reflux disease (GERD) a common cause for medical gastroenterology assessment and treatment. Richter and associates reported that 25-40% of Americans experience symptomatic GERD at some point; moreover, around 7-10% of Americans experience symptoms of GERD on a daily basis [1]. A typical set of symptoms includes heartburn, regurgitation, and dysphagia [2]. Nevertheless, a minority of patients could suffer from GERD, even in the absence of these symptoms, because abnormal reflux can also cause atypical (extraesophageal) symptoms, such as coughing, chest pain, and wheezing [3]. Epidemiologically, because many individuals try to control symptoms using over-the-counter (OTCs) medication without consulting a medical professional, the actual number of individuals with GERD is probably higher than estimated [4]. Numerous studies, developed worldwide, have assessed the associations between dental erosions or other linked oral manifestations and GERD, because of the impaired salivary ph and flow in GERD patients adequate salivary secretions being considered mandatory for the protection of both teeth and esophageal mucosa [5]. Treatment of GERD involves a stepwise approach starting from lifestyle modification towards control of gastric acid secretion through medical therapy with antiacids or PPIs or surgical treatment with corrective antireflux surgery [6-8]. Improvement of salivary secretions and diminishment of dental manifestations are therefore expected. The aim of the study was to evaluate the possible correlation between various early treatments and management options for GERD and subsequent International Journal of Medical Dentistry 289

2 Andrei Vasile OLTEANU, Dana Elena MITRICĂ, Gheorghe Gh. BĂLAN, Carmen SAVIN, Adriana BĂLAN control of oral manifestations, taking as premises that both conservative management (diet and lifestyle changes) and PPIs may positively influence the disorders regarding salivary secretions, and therefore may be a useful resource in managing the associated oral conditions. 2. MATERIALS AND METHODS In 2005, the American College of Gastroenterology (ACG) published updated guidelines for the diagnosis and treatment of GERD, according to which, for patients with symptoms and history consistent with uncomplicated GERD, the diagnosis of GERD may be assumed only by clinical examination and history talking, and empirical therapy may be initiated [3]. 48 naive clinically diagnosed GERD adult patients with oral manifestations, mainly erosions, were included in the study, none of which showing alarming symptoms (nausea, vomiting, severe regurgitation, weight loss or hemorrhage) that would require further gastroenterology assessment. Oral examination was performed by a trained dentist, alongside clinical examination and history talking performed by a gastroenterologist. Assessment of patients was done in each case in the morning, on an empty stomach, after proper morning dental hygiene. Dental examination evaluated the DMF index (decayed, missing, filled), as described by Cappelli et al. [9], and the OHI-S index (Simplified Oral Hygiene), as described by the Malmo University team [10]. Salivary flow was also evaluated by the Saxon test described by Kohler et al., 1985, patients being measured as to the quantity of salivary secretions after chewing on a folded sterile sponge for 2 min [11]. Proper informed consent for study inclusion was obtained from all patients. Further guideline acknowledged management options [3] were PPIs therapy (omeprazole 20mg PO qd in the morning, 30 min before breakfast, for 4 weeks) and dietary and lifestyle changes, as showed in Table patients were prescribed dietary and lifestyle measures and PPIs Group A, whereas 23 patients were managed only through dietary and lifestyle modifications Group B. General assessment was performed in the same conditions, by the same professionals, at the time of diagnosis and 4 weeks afterwards. Table 1. Dietary and lifestyle changes prescribed in managing GERD Losing weight in all patients with BMI over 25 kg/sqm Avoiding alcohol, chocolate, citrus juice, and tomato-based products, peppermint, coffee and onion Avoiding large meals Waiting 3 hr after a meal before lying down Elevating the head of the bed 30 cm Maintaining proper oral hygiene teeth brushing after meals at least 2 times a day Including at least a daily diet of 2 L liquids Each patient was graded an OHI-S index between 0 and 6, before and after 4 weeks of management trial. Upon DMFT indexes evaluation, each patient was assessed the mean number of decayed, missing or filled teeth over 32 teeth examination, the parameters studied being listed in Table 2. Saxon test values were described for each patient by salivary flow mass. 290 volume 19 Issue 4 October / December 2015 pp

3 EFFECTS OF PROTON PUMP INHIBITORS ON DENTAL EROSIONS CAUSED BY GASTROESOPHAGEAL REFLUX DISEASE Table 2. DMFT parameters definition DMFT: Mean number of decayed, missing or filled teeth % DMFT Percentage of population affected with dental caries Percentage of population with untreated decayed teeth MT Mean number of missing teeth %D MNT Mean number of teeth DT Mean number of decayed teeth %Ed Percentage of edentulous population 3. RESULTS AND DISCUSSION The mean OHI-S index among patients of group A was 4.52 before therapy and 2.92 after therapy, whereas the indexes of group B patients dropped from a mean value of 4.56 before, to 2.91 after dietary and lifestyle management (p < ). Mean DMFT parameters studied over 32 teeth before and after therapy trial are showed in Table 3 for group A and in Table 4 for group B, respectively. As to the salivary flow, the mean Saxon test index dropped from 3.85 g/2 min to 2.73 g/2 min in group A, and from 4.10 g/2 min to 2.85 g/2 min in group B, respectively. Table 3. Mean DMFT parameters for group A Before trial After trial Before trial After trial % DMFT MT 1 1 %D MNT DT 3 3 %Ed Table 4. Mean DMFT parameters for group B Before trial After trial Before trial After trial % DMFT MT 1 1 %D MNT DT 4 4 %Ed As expected, no significant differences were recorded in the DMF index, OHI-S index or Saxon test along the 4 week management between the groups. Otherwise, improvement in OHI-S indexes and Saxon test quantifier inside the same study group before and after management trial was detected. Diet and lifestyle changes seem to be sufficient for limiting and preventing further vitality, aestethics and function loss of the affected teeth. Dietary factors are also thought to be the most important risk factors for dental erosion [12]. Nevertheless, even more significant changes after dietary measures were found in childern by International Journal of Medical Dentistry 291

4 Andrei Vasile OLTEANU, Dana Elena MITRICĂ, Gheorghe Gh. BĂLAN, Carmen SAVIN, Adriana BĂLAN Huang et al., 2014 [13]. On the other hand, prevention of chronic acid regurgitation is mandatory in the management of tooth erosion, and a recent Cochrane review found out that PPIs were the most effective in controling acid reflux [14]. In this respect, another review article stated that the effectiveness of PPIs in relieving regurgitation symptoms in adults was modest and lower than that for heartburn, raising questions on the need for a more effective treatment [15]. Subsequently, another Cochrane review confirmed the more effective relief of symptoms by surgery (laparoscopic Nissen fundoplication) compared with medication therapy [16]. Furthermore, the development of novel techniques for the diagnosis and management of GERD confirms the true complexity of the GERD diagnosis and therapy and as also evidenced in our study the much lower effectiveness of PPIs [17]. Complete cessation of nocturnal acid regurgitation may be difficult to achieve only by pharmacologic treatment [18]. Interestingly however, awareness should be raised on any drugs or medicines consumed by patients that may cause or exacerbate hyposalivation and lead to xerostomia [18]. Tooth erosion is highly unlikely to be caused by alkaline bile juices from duodenogastroesophageal regurgitation (DGER) [19]. 4. CONCLUSIONS Analysis of GERD-associated manifestations in the oral cavity showed that dental erosions, halitosis, oral transient burning sensation, mucosal ulcerations, dysgeusia or loss of taste and both xerostomia and increased salivary flow may be secondary to the acid reflux. Pathogenically, dental erosions and/or cavities of GERD patients appear to be mainly caused by impaired salivary secretions and flow, otherwise no - positive or negative - effect could be secondary to PPI therapy. No statistically significant difference was found between the oral impact of PPIs plus diet and lifestyle changes therapy versus diet and lifestyle changes alone. Therefore, in relationship to the extra-digestive management of GERD patients, diet and lifestyle changes appear as sufficient for controlling oral and dental manifestations. On the other hand, complex oral rehabilitation of GERD patients and collaboration between gastroenterologists and dentists should be promoted. References 1. Herbella FA, Sweet MP, Tedesco P, Nipomnick I, Patti MG. Gastroesophageal reflux disease and obesity. Pathophysiology and implications for treatment. J Gastrointest Surg. 2007; 11(3): Sveen S. Symptom check: is it GERD? J Contin Educ Nurs. 2009; 40(3): DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005; 100(1): Spechler SJ. Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion. 1992; 51(1): Di Fede O, Di Liberto C, Occhipinti G, Vigneri S, Lo Russo L, Fedele S, Lo Muzio L, Campisi G. Oral manifestations in patients with gastro-oesophageal reflux disease: a single-center case control study. J Oral Pathol Med. 2008; 37(6): Giannini EG, Zentilin P, Dulbecco P, Vigneri S, Scarlata P, Savarino V. Management strategy for patients with gastroesophageal reflux disease: a comparison between empirical treatment with esomeprazole and endoscopy-oriented treatment. Am J Gastroenterol. 2008; 103(2): Katz PO. Medical therapy for gastroesophageal reflux disease in Rev Gastroenterol Disord. 2007; 7(4): Fass R, Sifrim D. Management of heartburn not responding to proton pump inhibitors. Gut. 2009; 58(2): Cappelli DP, Mobley CC. Prevention in Clinical Oral Health Care. Philadelphia: Mosby Elsevier; Greene JC, Vermillion JR. Simplified Oral Hygiene Index [internet] 2015 [cited 2015 Sept] 11. available from: Methods-and-Indices/Oral-Hygiene-Indices/ Simplified-Oral-Hygiene-Index--OHI-S/. 12. Kohler PF, Winter ME. A quantitative test for xerostomia. The Saxon test, an oral equivalent of the Schirmer test. Arthritis Rheum. 1985; 28(10): Wang X, Lussi A. Assessment and management of dental erosion. Dent Clin North Am. 2010; 54(3): Huang LL, Leishman S, Newman B, Seow WK. Association of erosion with timing of detection and 292 volume 19 Issue 4 October / December 2015 pp

5 EFFECTS OF PROTON PUMP INHIBITORS ON DENTAL EROSIONS CAUSED BY GASTROESOPHAGEAL REFLUX DISEASE selected risk factors in primary dentition: a longitudinal study. Int J Paediatr Dent. 2015; 25: Van Pinxteren B, Sigterman KE, Bonis P, Lau J, Numans ME. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux diseaselike symptoms and endoscopy negative reflux disease. Cochrane Database Syst. Rev. 2010; (11): CD Kahrilas PJ, Howden CW, Hughes N. Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease. Am. J. Gastroenterol. 2011; 106: Wileman SM, McCann S,Grant AM, Krukowski ZH, Bruce J. Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adults. Cochrane Database Syst. Rev. 2010; (3):CD Sifrim D, Lundell L, Zerbib F. Gastro-oesophageal reflux disease. Best Pract. Res. Clin. Gastroenterol. 2010; 24(6): Ranjitkar S, Kaidonis JA, Smales RJ. Gastroesophageal reflux disease and tooth erosion. Int J Dent. 2012; 2012: Koek GH, Tack J, Sifrim D, Lerut T, Janssens J. The role of acid and duodenal gastroesophageal reflux in symptomatic GERD. Am. J. Gastroenterol. 2001; 96(7): International Journal of Medical Dentistry 293

EXTRAESOPHAGEAL MANIFESTATIONS OF GASTROESOPHAGEAL REFLUX DISEASE WITH IMPLICATIONS FOR ORAL CAVITY

EXTRAESOPHAGEAL MANIFESTATIONS OF GASTROESOPHAGEAL REFLUX DISEASE WITH IMPLICATIONS FOR ORAL CAVITY EXTRAESOPHAGEAL MANIFESTATIONS OF GASTROESOPHAGEAL REFLUX DISEASE WITH IMPLICATIONS FOR ORAL CAVITY Crînguţa Paraschiv*, Cristina Gavrilescu, Irina Cotea, Manea Paloma, Rodica Ghiuru Gr. T. Popa" U.M.Ph.

More information

Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease (GERD) Gastroesophageal Reflux Disease (GERD) Acid Reflux Acid reflux occurs when acid from the stomach moves backwards into the esophagus. Heartburn Heartburn is a symptom of acid reflux and GERD. It may feel

More information

Hold the Wrap! There is so much more to be done!

Hold the Wrap! There is so much more to be done! Hold the Wrap! There is so much more to be done! (Well, a few things that can be done.) (Well, not all that much, really ) (But Blair has never killed anyone with a PPI!) Nicholas Shaheen, MD, MPH Center

More information

Medical Policy Manual. Topic: Gastric Reflux Surgery Date of Origin: November Section: Surgery Last Reviewed Date: March 2014

Medical Policy Manual. Topic: Gastric Reflux Surgery Date of Origin: November Section: Surgery Last Reviewed Date: March 2014 Medical Policy Manual Topic: Gastric Reflux Surgery Date of Origin: November 2012 Section: Surgery Last Reviewed Date: March 2014 Policy No: 186 Effective Date: May 1, 2014 IMPORTANT REMINDER Medical Policies

More information

GERD: A linical Clinical Clinical Update Objectives

GERD: A linical Clinical Clinical Update Objectives GERD: A Clinical Update Jeff Gilbert, M.D. University i of Kentucky Gastroenterology 11/6/08 Objectives To review the basic pathophysiology underlying gastroesophageal reflux disease To highlight current

More information

ACG Clinical Guideline: Diagnosis and Management of Gastroesophageal Reflux Disease

ACG Clinical Guideline: Diagnosis and Management of Gastroesophageal Reflux Disease ACG Clinical Guideline: Diagnosis and Management of Gastroesophageal Reflux Disease Philip O. Katz MD 1, Lauren B. Gerson MD, MSc 2 and Marcelo F. Vela MD, MSCR 3 1 Division of Gastroenterology, Einstein

More information

Unmet Needs in the Management of Gastroesophageal Reflux Disease

Unmet Needs in the Management of Gastroesophageal Reflux Disease Unmet Needs in the Management of Gastroesophageal Reflux Disease Ronnie Fass MD Professor of Medicine Case Western Reserve University Chairman, Division of Gastroenterology and Hepatology Director, Esophageal

More information

Burning Issues in Gastroesophageal Reflux Disease (GERD)

Burning Issues in Gastroesophageal Reflux Disease (GERD) 3:45 4:45pm Burning Issues in GERD SPEAKER Prateek Sharma, MD, FACG, FACP Presenter Disclosure Information The following relationships exist related to this presentation: Prateek Sharma, MD, FACG, FACP,

More information

GERD DIAGNOSIS & TREATMENT DISCLOSURES 4/18/2018

GERD DIAGNOSIS & TREATMENT DISCLOSURES 4/18/2018 GERD DIAGNOSIS & TREATMENT Subhash Chandra MBBS Assistant Professor CHI Health Clinic Gastroenterology Creighton University, School of Medicine April 28, 2018 DISCLOSURES None 1 OBJECTIVES Review update

More information

GERD. Gastroesophageal reflux disease, or GERD, occurs when acid from the. stomach backs up into the esophagus. Normally, food travels from the

GERD. Gastroesophageal reflux disease, or GERD, occurs when acid from the. stomach backs up into the esophagus. Normally, food travels from the GERD What is GERD? Gastroesophageal reflux disease, or GERD, occurs when acid from the stomach backs up into the esophagus. Normally, food travels from the mouth, down through the esophagus and into the

More information

SASKATCHEWAN REGISTERED NURSES ASSOCIATION

SASKATCHEWAN REGISTERED NURSES ASSOCIATION DEFINITION Reflux of gastric contents into the esophagus, which results in esophageal irritation or inflammation. IMMEDIATE CONSULTATION REQUIRED IN THE FOLLOWING SITUATIONS Dysphagia (solid food, progressive)

More information

Putting Chronic Heartburn On Ice

Putting Chronic Heartburn On Ice Putting Chronic Heartburn On Ice Over the years, gastroesophageal reflux disease has proven to be one of the most common complaints facing family physicians. With quicker diagnosis, this pesky ailment

More information

Maximizing Outcome of Extraesophageal Reflux Disease. (GERD) is often accompanied

Maximizing Outcome of Extraesophageal Reflux Disease. (GERD) is often accompanied ...PRESENTATIONS... Maximizing Outcome of Extraesophageal Reflux Disease Based on a presentation by Peter J. Kahrilas, MD Presentation Summary Gastroesophageal reflux disease (GERD) accompanied by regurgitation

More information

Reflux of gastric contents, particularly acid, into the esophagus

Reflux of gastric contents, particularly acid, into the esophagus Heartburn Reflux of gastric contents, particularly acid, into the esophagus Patient assessment with GERD 1-signs and symptoms The hallmark of typical symptom of GERD is heartburn (restrosternal),acid regurgitation,

More information

Heartburn. Understanding and Treating. Heal n Cure For appointments call

Heartburn. Understanding and Treating. Heal n Cure For appointments call A C P S P E C I A L R E P O R T Understanding and Treating Heartburn What is Heartburn? It begins as a burning pain in the middle of your chest, behind the breastbone, often after a big meal. The burning

More information

TBURN TBURN BURN ARTBURN EARTBURN EART HEARTBURN: HOW TO GET IT OFF YOUR CHEST

TBURN TBURN BURN ARTBURN EARTBURN EART HEARTBURN: HOW TO GET IT OFF YOUR CHEST TBURN BURN TBURN ARTBURN. EARTBURN EART N EARTBURN HEARTBURN: HOW TO GET IT OFF YOUR CHEST Do you sometimes wake up at night with a sharp, burning sensation in your chest? Does this sometimes happen during

More information

GASTROESOPHAGEAL REFLUX DISEASE. William M. Brady

GASTROESOPHAGEAL REFLUX DISEASE. William M. Brady Drugs of Today 1998, 34(1): 25-30 Copyright PROUS SCIENCE GASTROESOPHAGEAL REFLUX DISEASE William M. Brady Section of General Internal Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania,

More information

Gastroesophageal Reflux Disease, Paraesophageal Hernias &

Gastroesophageal Reflux Disease, Paraesophageal Hernias & 530.81 553.3 & 530.00 43289, 43659 1043432842, MD Assistant Clinical Professor of Surgery, UH JABSOM Associate General Surgery Program Director Director of Minimally Invasive & Bariatric Surgery Programs

More information

Page 1. Objectives. The Role of the Pharmacist as Gatekeeper to the Appropriate Use of OTC PPI Therapy in Frequent Heartburn

Page 1. Objectives. The Role of the Pharmacist as Gatekeeper to the Appropriate Use of OTC PPI Therapy in Frequent Heartburn Page 1 The Role of the Pharmacist as Gatekeeper to the Appropriate Use of OTC PPI Therapy in The Role of the Pharmacist as Gatekeeper to the Appropriate Use of OTC PPI Therapy in Colin W. Howden, MD, FRCP

More information

Disclosures. Proton Pump Inhibitors Deprescribing? Deprescribing PPI Objectives. Deprescribing. Proton Pump Inhibitors (PPI) 5/28/2018.

Disclosures. Proton Pump Inhibitors Deprescribing? Deprescribing PPI Objectives. Deprescribing. Proton Pump Inhibitors (PPI) 5/28/2018. Proton Pump Inhibitors Deprescribing? None Disclosures Chad Burski, MD Assistant Professor of Medicine UAB Gastroenterology Deprescribing PPI Objectives AR Why? Who? How? The mechanism of action of Proton

More information

Review article: gastric acidity ) comparison of esomeprazole with other proton pump inhibitors

Review article: gastric acidity ) comparison of esomeprazole with other proton pump inhibitors Aliment Pharmacol Ther 2003; 17 (Suppl. 1): 10 15. Review article: gastric acidity ) comparison of esomeprazole with other proton pump inhibitors J. G. HATLEBAKK Department of Medicine, Haukeland Sykehus,

More information

GASTRO-OESOPHAGEAL REFLUX DR RONALDA DELACY

GASTRO-OESOPHAGEAL REFLUX DR RONALDA DELACY GASTRO-OESOPHAGEAL REFLUX DR RONALDA DELACY DEFINITIONS GERD -Involuntary, effortless passage of gastric contents into the oesophagus +/-ejected from the mouth resulting in troublesome symptoms or complications

More information

June By: Reza Gholami

June By: Reza Gholami ACG/CAG guideline on Management of Dyspepsia June 2017 By: Reza Gholami DEFINITION OF DYSPEPSIA AND SCOPE OF THE GUIDELINE Dyspepsia was originally defined as any symptoms referable to the upper gastrointestinal

More information

Nonerosive reflux disease as a presentation of gastro-oesophageal reflux disease

Nonerosive reflux disease as a presentation of gastro-oesophageal reflux disease Nonerosive reflux disease as a presentation of gastro-oesophageal reflux disease Abstract Simmonds WM, MMed (Internal Medicine) Gastroenterology Fellow, Department of Internal Medicine, Free State University

More information

GERD: 2014 Dilemmas and Solutions. Ronnie Fass MD, FACP Professor of Medicine Case Western Reserve University

GERD: 2014 Dilemmas and Solutions. Ronnie Fass MD, FACP Professor of Medicine Case Western Reserve University GERD: 2014 Dilemmas and Solutions Ronnie Fass MD, FACP Professor of Medicine Case Western Reserve University How to Maximize Your PPI Treatment? Improve compliance and adherance Fass R. Am J Gastroenterol.

More information

WHAT IS GASTROESOPHAGEAL REFLUX DISEASE (GERD)?

WHAT IS GASTROESOPHAGEAL REFLUX DISEASE (GERD)? WHAT IS GASTROESOPHAGEAL REFLUX DISEASE (GERD)? The term gastroesophageal reflux describes the movement (or reflux) of stomach contents back up into the esophagus, the muscular tube that extends from the

More information

ACID REFLUX & GERD: The Unsettling Reality in Canada

ACID REFLUX & GERD: The Unsettling Reality in Canada ACID REFLUX & GERD: The Unsettling Reality in Canada gerd fact 1 see page 8 Canadian Society of Intestinal Research On average, ARD patients wait over two years before seeking care 1. 1 gerd fact 2 see

More information

Definition: gas tro e soph a ge al re f lux dis ease (GERD) from Stedman's Medical Dictionary for the Health Professions and Nursing

Definition: gas tro e soph a ge al re f lux dis ease (GERD) from Stedman's Medical Dictionary for the Health Professions and Nursing Topic Page: Gastroesophageal reflux Definition: gas tro e soph a ge al re f lux dis ease (GERD) from Stedman's Medical Dictionary for the Health Professions and Nursing (gas trō-ĕ-sof ă-jē ăl rē flŭks

More information

GERD: Pitfalls and Pearls

GERD: Pitfalls and Pearls GERD: Pitfalls and Pearls Gary W. Falk, M.D., M.S. Professor of Medicine Division of Gastroenterology Perelman School of Medicine of the University of Pennsylvania Conflicts of Interest Nothing to disclose

More information

OTC PPI Therapy in Frequent Heartburn

OTC PPI Therapy in Frequent Heartburn Page 1 Gate Keeper to the Appropriate Use of OTC PPI Therapy for Conflicts of Interest Gatekeeper to the Appropriate Use of OTC PPI Therapy in Colin W. Howden, MD, FRCP (Glasg), FACP, FACG, FCP Professor

More information

Silent reflux (also known as LPR or EOR)

Silent reflux (also known as LPR or EOR) ENT - Information for patients Silent reflux (also known as LPR or EOR) Introduction This leaflet explains what your condition is, why it happens, what the symptoms are and how it can be managed. If there

More information

Refractory GERD. Kenneth R. DeVault, MD, FACG President American College of Gastroenterology Chair Department of Medicine Mayo Clinic Florida

Refractory GERD. Kenneth R. DeVault, MD, FACG President American College of Gastroenterology Chair Department of Medicine Mayo Clinic Florida Refractory GERD Kenneth R. DeVault, MD, FACG President American College of Gastroenterology Chair Department of Medicine Mayo Clinic Florida Objectives Define the terminology associated with refractory

More information

History. Prevalence at Endoscopy. Prevalence and Reflux Sx. Prevalence at Endoscopy. Barrett s Esophagus: Controversy and Management

History. Prevalence at Endoscopy. Prevalence and Reflux Sx. Prevalence at Endoscopy. Barrett s Esophagus: Controversy and Management Barrett s Esophagus: Controversy and Management History Norman Barrett (1950) Chronic Peptic Ulcer of the Oesophagus and Oesophagitis Allison and Johnstone (1953) The Oesophagus Lined with Gastric Mucous

More information

Four-Day Bravo ph Capsule Monitoring With and Without Proton Pump Inhibitor Therapy

Four-Day Bravo ph Capsule Monitoring With and Without Proton Pump Inhibitor Therapy CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:1083 1088 Four-Day Bravo ph Capsule Monitoring With and Without Proton Pump Inhibitor Therapy IKUO HIRANO, QING ZHANG, JOHN E. PANDOLFINO, and PETER J. KAHRILAS

More information

Achalasia is a rare disease with an annual incidence estimated REVIEWS. Erroneous Diagnosis of Gastroesophageal Reflux Disease in Achalasia

Achalasia is a rare disease with an annual incidence estimated REVIEWS. Erroneous Diagnosis of Gastroesophageal Reflux Disease in Achalasia CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2011;9:1020 1024 REVIEWS Erroneous Diagnosis of Gastroesophageal Reflux Disease in Achalasia BOUDEWIJN F. KESSING, ALBERT J. BREDENOORD, and ANDRÉ J. P. M. SMOUT

More information

Validation of a Four-Graded Scale for Severity of Heartburn in Patients with Symptoms of Gastroesophageal Reflux Disease

Validation of a Four-Graded Scale for Severity of Heartburn in Patients with Symptoms of Gastroesophageal Reflux Disease Volume 11 Number 4 2008 VALUE IN HEALTH Validation of a Four-Graded Scale for Severity of Heartburn in Patients with Symptoms of Gastroesophageal Reflux Disease Ola Junghard, PhD, 1 Ingela Wiklund, PhD

More information

Patient information. Laryngopharyngeal Reflux ( LPR) Ear Nose and Throat Directorate PIF 1423/V4

Patient information. Laryngopharyngeal Reflux ( LPR) Ear Nose and Throat Directorate PIF 1423/V4 Patient information Laryngopharyngeal Reflux ( LPR) Ear Nose and Throat Directorate PIF 1423/V4 You have been diagnosed with laryngopharyngeal reflux (LPR), otherwise known as extra-oesophageal reflux

More information

Barrett s Oesophagus Information Leaflet THE DIGESTIVE SYSTEM. gutscharity.org.

Barrett s Oesophagus Information Leaflet THE DIGESTIVE SYSTEM.   gutscharity.org. THE DIGESTIVE SYSTEM http://healthfavo.com/digestive-system-for-kids.html This factsheet is about Barrett s Oesophagus Barrett s Oesophagus is the term used for a pre-cancerous condition where the normal

More information

A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing?

A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Alimentary Pharmacology and Therapeutics A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? P. O. Katz*, D. A. Johnson

More information

Clinical Study Management of Gastroesophageal Reflux Disease: A Review of Medical and Surgical Management

Clinical Study Management of Gastroesophageal Reflux Disease: A Review of Medical and Surgical Management Hindawi Publishing Corporation Minimally Invasive Surgery Volume 2014, Article ID 654607, 5 pages http://dx.doi.org/10.1155/2014/654607 Clinical Study Management of Gastroesophageal Reflux Disease: A Review

More information

Effective Health Care

Effective Health Care Effective Health Care Comparative Effectiveness of Management Strategies for Gastroesophageal Reflux Disease Executive Summary Background Gastroesophageal reflux disease (GERD), defined as weekly heartburn

More information

Disclosures. Heartburn and Barrett s Esophagus. Heartburn and Barrett s Esophagus. GERD is common in the U.S. None

Disclosures. Heartburn and Barrett s Esophagus. Heartburn and Barrett s Esophagus. GERD is common in the U.S. None Heartburn and Barrett s Esophagus None Disclosures Christian Mathy, MD University of California, San Francisco 2015 Heartburn and Barrett s Esophagus Heartburn and GERD GERD therapy Extraesophageal GERD

More information

GASTROESOPHAGEAL REFLUX

GASTROESOPHAGEAL REFLUX DR. PHILIP K. BLUSTEIN M.D. F.R.C.P.(C) 415 14 TH ST. NW. CALGARY AB T2N2A1 PHONE (403) 270-9555 FAX (404) 270-7479 GASTROESOPHAGEAL REFLUX DEFINITION: *MONTREAL CONSENSUS DEFINED GERD AS A CONDITION WHICH

More information

Refractory GERD: What s a Gastroenterologist To Do?

Refractory GERD: What s a Gastroenterologist To Do? Refractory GERD: What s a Gastroenterologist To Do? Philip O. Katz, MD, FACG Chairman, Division of Gastroenterology Einstein Medical Center Clinical Professor of Medicine Jefferson Medical College Philadelphia,

More information

Refractory GERD : case presentation and discussion

Refractory GERD : case presentation and discussion Refractory GERD : case presentation and discussion Ping-Huei Tseng National Taiwan University Hospital May 19, 2018 How effective is PPI based on EGD? With GERD symptom 75% erosive 25% NERD Endoscopy 81%

More information

Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease (GERD) Gastroesophageal Reflux Disease (GERD) Information for patients UHN Read this handout to learn about: What gastroesohageal reflux (GERD) is Signs and symptoms How your doctor will know if you have it Tests

More information

4/24/2015. History of Reflux Surgery. Recent Innovations in the Surgical Treatment of Reflux

4/24/2015. History of Reflux Surgery. Recent Innovations in the Surgical Treatment of Reflux Recent Innovations in the Surgical Treatment of Reflux Scott Carpenter, DO, FACOS, FACS Mercy Hospital Ardmore Ardmore, OK History of Reflux Surgery - 18 th century- first use of term heartburn - 1934-

More information

Heartburn Overview. Causes & Risk Factors

Heartburn Overview. Causes & Risk Factors Return to Web version Heartburn Overview What is heartburn? Despite its name, heartburn doesn't affect the heart. Heartburn is a burning feeling in the lower chest, along with a sour or bitter taste in

More information

Nexium 24HR. Tools and information for you and your pharmacy team NOW OTC FOR FREQUENT HEARTBURN. Consumer Healthcare Pfizer Inc.

Nexium 24HR. Tools and information for you and your pharmacy team NOW OTC FOR FREQUENT HEARTBURN. Consumer Healthcare Pfizer Inc. NOW OTC FOR FREQUENT HEARTBURN w e N Nexium 24HR P H A R M A S S I S T K I T Tools and information for you and your pharmacy team 2014 Pfizer Inc. NXM041468 05/14 Q: What is the indication for Nexium 24HR

More information

Eosinophilic Esophagitis (EoE)

Eosinophilic Esophagitis (EoE) Eosinophilic Esophagitis (EoE) 01.06.2016 EoE: immune-mediated disorder food or environmental antigens => Th2 inflammatory response. Key cytokines: IL-4, IL-5, and IL-13 stimulate the production of eotaxin-3

More information

Review article: the measurement of non-acid gastro-oesophageal reflux

Review article: the measurement of non-acid gastro-oesophageal reflux Alimentary Pharmacology & Therapeutics Review article: the measurement of non-acid gastro-oesophageal reflux A. J. P. M. SMOUT Department of Gastroenterology, University Medical Center Utrecht, Utrecht,

More information

Gastroesophageal reflux (GER) Gastroesophageal reflux (GER), the passage of gastric contents into the esophagus, is a normal physiologic process that

Gastroesophageal reflux (GER) Gastroesophageal reflux (GER), the passage of gastric contents into the esophagus, is a normal physiologic process that Gastroesophageal reflux (GER) Gastroesophageal reflux (GER), the passage of gastric contents into the esophagus, is a normal physiologic process that may occur daily in healthy infants, children and adults.

More information

Relieving Frequent Heartburn Day Through Night

Relieving Frequent Heartburn Day Through Night Page 1 Relieving Frequent Heartburn Day Through Night Relieving Frequent Heartburn Day Through Night David Metz, MD Professor of Medicine University of Pennsylvania School of Medicine Philadelphia, PA

More information

July 19, Division of Dockets Management Food and Drug Administration 5630 Fishers Lane Room 1061, HFA-305 Rockville, Maryland 20852

July 19, Division of Dockets Management Food and Drug Administration 5630 Fishers Lane Room 1061, HFA-305 Rockville, Maryland 20852 July 19, 2017 Division of Dockets Management Food and Drug Administration 5630 Fishers Lane Room 1061, HFA-305 Rockville, Maryland 20852 Re: Comments on Citizen s Petition #FDA-2017-P-2733 Herein, the

More information

Laparoscopic Anti-Reflux (GERD) Surgery Patient Information from SAGES

Laparoscopic Anti-Reflux (GERD) Surgery Patient Information from SAGES SAGES Society of American Gastrointestinal and Endoscopic Surgeons https://www.sages.org Laparoscopic Anti-Reflux (GERD) Surgery Patient Information from SAGES Author : SAGES Webmaster Surgery for Heartburn

More information

Gastro esophageal reflux disease DR. AMMAR I. ABDUL-LATIF

Gastro esophageal reflux disease DR. AMMAR I. ABDUL-LATIF Gastro esophageal reflux disease )GERD( DR. AMMAR I. ABDUL-LATIF GERD DEFINITION EPIDEMIOLOGY CAUSES PATHOGENESIS SIGNS &SYMPTOMS COMPLICATIONS DIAGNOSIS TREATMENT Definition Montreal consensus defined

More information

James Paget University Hospitals. NHS Foundation Trust. Hiatus hernia. Patient Information

James Paget University Hospitals. NHS Foundation Trust. Hiatus hernia. Patient Information James Paget University Hospitals NHS Foundation Trust Hiatus hernia Patient Information What is a hiatus hernia? A hiatus hernia can cause highly irritating stomach contents, such as acid, to move up into

More information

Patients with refractory gastroesophageal reflux disease: diagnostic tools

Patients with refractory gastroesophageal reflux disease: diagnostic tools INVITED REVIEW Annals of Gastroenterology (2012) 25, 1-6 Patients with refractory gastroesophageal reflux disease: diagnostic tools Georgios P. Karamanolis a, Daniel Sifrim b Aretaieion Hospital, Athens

More information

Understanding GERD. & Stretta Therapy. GERD (gĕrd): Gastroesophageal Reflux Disease

Understanding GERD. & Stretta Therapy. GERD (gĕrd): Gastroesophageal Reflux Disease Understanding GERD & Stretta Therapy GERD (gĕrd): Gastroesophageal Reflux Disease What is GERD? When the muscle between your stomach and esophagus is weak, stomach contents like acid or bile can reflux

More information

Guidelines for the Management of Dyspepsia and GORD. Gastroenterology/ Acute Adult Governance. Drugs and Therapeutics Committee

Guidelines for the Management of Dyspepsia and GORD. Gastroenterology/ Acute Adult Governance. Drugs and Therapeutics Committee Guidelines for the Management of Dyspepsia and GORD Document type: Version: 3.0 Author (name): Author (designation): Validated by Prescribing Dr. G. Lipscomb Date validated October 2015 Ratified by: Date

More information

DYSPEPSIA Dyspepsia indigestion during or after eating Full Heat, burning or pain Note: one of every four people

DYSPEPSIA Dyspepsia indigestion during or after eating Full Heat, burning or pain Note: one of every four people What Is Dyspepsia? Dyspepsia, also known as indigestion, can have multiple symptoms. Feelings of indigestion happen during or after eating. If you have indigestion you might feel: Full during a meal. Painful

More information

Heartburn, also referred to acid reflux, happens when stomach acid flows back (refluxes) into your esophagus.

Heartburn, also referred to acid reflux, happens when stomach acid flows back (refluxes) into your esophagus. WHILE almost everyone experiences mild heartburn from time to time and many individuals have some antacids or another medication on hand for its relief, talk to your doctor, if you have heartburn more

More information

Page 1 of 5 Official reprint from UpToDate www.uptodate.com 2017 UpToDate Patient education: Acid reflux (gastroesophageal reflux disease) in adults (The Basics) Written by the doctors and editors at UpToDate

More information

Review Article Impact of Laparoscopic Fundoplication for the Treatment of Laryngopharyngeal Reflux: Review of the Literature

Review Article Impact of Laparoscopic Fundoplication for the Treatment of Laryngopharyngeal Reflux: Review of the Literature International Otolaryngology Volume 2012, Article ID 291472, 4 pages doi:10.1155/2012/291472 Review Article Impact of Laparoscopic Fundoplication for the Treatment of Laryngopharyngeal Reflux: Review of

More information

Speaker disclosure. Objectives. GERD: Who and When to Treat 7/21/2015

Speaker disclosure. Objectives. GERD: Who and When to Treat 7/21/2015 GERD: Who and When to Treat Eugenio J Hernandez, MD Gastrohealth, PL Assistant Professor of Clinical Medicine, FIU Herbert Wertheim School of Medicine Speaker disclosure I do not have any relevant commercial

More information

Module 2 Heartburn Glossary

Module 2 Heartburn Glossary Absorption Antacids Antibiotic Module 2 Heartburn Glossary Barrett s oesophagus Bloating Body mass index Burping Chief cells Colon Digestion Endoscopy Enteroendocrine cells Epiglottis Epithelium Absorption

More information

Rpts. GENERAL General Schedule (Code GE) Program Prescriber type: Dental Medical Practitioners Nurse practitioners Optometrists Midwives

Rpts. GENERAL General Schedule (Code GE) Program Prescriber type: Dental Medical Practitioners Nurse practitioners Optometrists Midwives Esomeprazole 20mg Name, Restriction, Manner of esomeprazole 20 mg enteric tablet, 30 (8886Q) (029W) Gastric ulcer Peptic ulcer Treatment Phase: Initial treatment The therapy must be for initial treatment

More information

ORIGINAL ARTICLES ALIMENTARY TRACT

ORIGINAL ARTICLES ALIMENTARY TRACT CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2012;10:612 619 ORIGINAL ARTICLES ALIMENTARY TRACT Regurgitation Is Less Responsive to Acid Suppression Than Heartburn in Patients With Gastroesophageal Reflux

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,800 116,000 120M Open access books available International authors and editors Downloads Our

More information

SURGERY LAPAROSCOPIC ANTI-REFLUX (GORD) SURGERY

SURGERY LAPAROSCOPIC ANTI-REFLUX (GORD) SURGERY LAPAROSCOPIC ANTI-REFLUX (GORD) If you suffer from heartburn, your surgeon may have recommended Laparoscopic Anti-reflux Surgery to treat this condition, technically referred to as Gastro-oesophageal Reflux

More information

You May Be at Risk. You are currently taking a proton pump inhibitor (PPI):

You May Be at Risk. You are currently taking a proton pump inhibitor (PPI): PPI You are currently taking a proton pump inhibitor (PPI): Dexlansoprazole (Dexilant ) Esomeprazole (Nexium ) Omeprazole (Losec, Olex ) Lansoprazole (Prevacid, Prevacid Fast Tab ) Pantoprazole sodium

More information

Dyspepsia. Dyspepsia covers upper abdominal pain, fullness, early satiety, bloating, and nausea.

Dyspepsia. Dyspepsia covers upper abdominal pain, fullness, early satiety, bloating, and nausea. Antacids Hawler medical university Collage of pharmacy/ fourth year /pharmacy practice Sham A. Talat Shareef (B.Sc. Msc. clinical pharmacy) 2017-2018 Sham_talat@yahoo.com Head of Department Of Clinical

More information

CMEARTICLE. WHAT CAN I DO IN MY PRACTICE? History. Daphne Ang 1, MBBS, FRCP (Edin), Choon How How 2, MMed, FCFP, Tiing Leong Ang 1, MBBS, FRCP (Edin)

CMEARTICLE. WHAT CAN I DO IN MY PRACTICE? History. Daphne Ang 1, MBBS, FRCP (Edin), Choon How How 2, MMed, FCFP, Tiing Leong Ang 1, MBBS, FRCP (Edin) Singapore Med J 2016; 57(10): 546-551 10.11622/smedj.2016167 CMEARTICLE Persistent gastro-oesophageal reflux symptoms despite proton pump inhibitor therapy Daphne Ang 1, MBBS, FRCP (Edin), Choon How How

More information

Peptic ulcer disease Disorders of the esophagus

Peptic ulcer disease Disorders of the esophagus Peptic ulcer disease Disorders of the esophagus Peptic ulcer disease Burning epigastric pain Exacerbated by fasting Improved with meals Ulcer: disruption of mucosal integrity >5 mm in size, with depth

More information

J Neurogastroenterol Motil, Vol. 16 No. 3 July, 2010 DOI: /jnm Journal of Neurogastroenterology and Motility

J Neurogastroenterol Motil, Vol. 16 No. 3 July, 2010 DOI: /jnm Journal of Neurogastroenterology and Motility ㅋ JNM J Neurogastroenterol Motil, Vol. 16 No. 3 July, 2010 DOI: 10.5056/jnm.2010.16.3.258 Journal of Neurogastroenterology and Motility Review The Role of Weakly Acidic Reflux in Proton Pump Inhibitor

More information

Gastro-oesophageal reflux disease and peptic ulcer disease. By: Dr. Singanamala Suman Assistant Professor Department of Pharm.D

Gastro-oesophageal reflux disease and peptic ulcer disease. By: Dr. Singanamala Suman Assistant Professor Department of Pharm.D Gastro-oesophageal reflux disease and peptic ulcer disease By: Dr. Singanamala Suman Assistant Professor Department of Pharm.D Gastro-oesophageal reflux disease and peptic ulcer disease Learning objectives:

More information

Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease where next?

Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease where next? Aliment Pharmacol Ther 2005; 22: 79 94. doi: 10.1111/j.1365-2036.2005.02531.x Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease where next? R. FASS, M. SHAPIRO, R. DEKEL

More information

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA o Patients of any age with ALARM signs should be referred through the 2-week referral system o Routine endoscopic investigation

More information

Gastroesophageal reflux disease. The case for improving patient education in primary care

Gastroesophageal reflux disease. The case for improving patient education in primary care Original Research Gastroesophageal reflux disease: The case for improving patient education in primary care This study reveals that something as simple as knowing when to take GERD medication is compromised

More information

QUICK QUERIES. Topical Questions, Sound Answers

QUICK QUERIES. Topical Questions, Sound Answers QUICK QUERIES Topical Questions, Sound Answers Dyspepsia: An Evidence-Based Approach Alan B. R. Thomson, MD, PhD, FRCPC, FACP, FACG Presented at the University of Alberta s Medical Grand Rounds, University

More information

FREQUENTLY ASKED QUESTIONS

FREQUENTLY ASKED QUESTIONS When it comes to your health, it s normal to have a lot of questions. Whether you ve got questions about when and where Nexium 24HR is available to purchase, or how Nexium 24HR works and should be taken,

More information

Omeprazole 10mg. Name, Restriction, Manner of administration and form OMEPRAZOLE omeprazole 10 mg enteric tablet, 30 (8332M) Max. Qty.

Omeprazole 10mg. Name, Restriction, Manner of administration and form OMEPRAZOLE omeprazole 10 mg enteric tablet, 30 (8332M) Max. Qty. Omeprazole 10mg Name, Restriction, Manner of administration and form omeprazole 10 mg enteric tablet, 30 (8332M) Gastro-oesophageal reflux disease Name, Restriction, Manner of administration and form omeprazole

More information

Committee Approval Date: October 14, 2014 Next Review Date: October 2015

Committee Approval Date: October 14, 2014 Next Review Date: October 2015 Medication Policy Manual Topic: esomeprazole-containing medications: - Nexium - Vimovo - esomeprazole strontium Policy No: dru039 Date of Origin: May 2001 Committee Approval Date: October 14, 2014 Next

More information

Nexium 24HR Pharmacy Training

Nexium 24HR Pharmacy Training Nexium 24HR Pharmacy Training Your pharmacist's advice is required. Always read the label. Use only as directed. If symptoms persist, consult your doctor/ healthcare professional. Pfizer Consumer Healthcare

More information

PATIENT INFORMATION FROM YOUR SURGEON & SAGES Laparoscopic Anti-Reflux (GERD) Surgery

PATIENT INFORMATION FROM YOUR SURGEON & SAGES Laparoscopic Anti-Reflux (GERD) Surgery Patient Information published on: 03/2004 by the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) PATIENT INFORMATION FROM YOUR SURGEON & SAGES Laparoscopic Anti-Reflux (GERD) Surgery

More information

GASTROINTESTINAL AND ANTIEMETIC DRUGS. Submitted by: Shaema M. Ali

GASTROINTESTINAL AND ANTIEMETIC DRUGS. Submitted by: Shaema M. Ali GASTROINTESTINAL AND ANTIEMETIC DRUGS Submitted by: Shaema M. Ali GASTROINTESTINAL AND ANTIEMETIC DRUGS by: Shaema M. Ali There are four common medical conditions involving the GI system 1) peptic ulcers

More information

Many patients with gastroesophageal reflux

Many patients with gastroesophageal reflux ... HEALTH ECONOMICS... Efficacy and Cost Effectiveness of Lansoprazole Versus Omeprazole in Maintenance Treatment of Symptomatic Gastroesophageal Reflux Disease Eva Vivian, PharmD; Anthony Morreale, PharmD,

More information

MANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)

MANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) Routine endoscopic investigation of patients of any age, presenting with dyspepsia

More information

Famotidine Extended Abstracts

Famotidine Extended Abstracts Famotidine Extended Abstracts I) Primary literature Summary Ciccone, Decktor, et. al. Efficacy and tolerability of famotidine in preventing heartburn and related symptoms of upper gastrointestinal discomfort.

More information

Identifying patients who may benefit from stepping down PPI treatment

Identifying patients who may benefit from stepping down PPI treatment CLINICAL AUDIT Identifying patients who may benefit from stepping down PPI treatment Valid to January 2024 bpac nz better medicin e This audit identifies patients who are prescribed the proton pump inhibitor

More information

Intragastric acidity during treatment with esomeprazole 40 mg twice daily or pantoprazole 40 mg twice daily a randomized, two-way crossover study

Intragastric acidity during treatment with esomeprazole 40 mg twice daily or pantoprazole 40 mg twice daily a randomized, two-way crossover study Aliment Pharmacol Ther 2005; 21: 963 967. doi: 10.1111/j.1365-2036.2005.02432.x Intragastric acidity during treatment with esomeprazole 40 mg twice daily or pantoprazole 40 mg twice daily a randomized,

More information

PRESCRIBING SUPPORT TEAM AUDIT: PROTON PUMP INHIBITOR PRESCRIBING REVIEW

PRESCRIBING SUPPORT TEAM AUDIT: PROTON PUMP INHIBITOR PRESCRIBING REVIEW PRESCRIBING SUPPORT TEAM AUDIT: PROTON PUMP INHIBITOR PRESCRIBING REVIEW DATE OF AUTHORISATION: AUTHORISING GP: PRESCRIBING SUPPORT TECHNICIAN: SUMMARY Dyspepsia refers to a broad range of symptoms related

More information

Gastroesophageal Reflux Disease:

Gastroesophageal Reflux Disease: Gastroesophageal Reflux Disease: Introduction Gastroesophageal reflux is the involuntary movement of gastric contents to the esophagus. It is a common disease, occurring in one third of the population

More information

The New GERD Guidelines

The New GERD Guidelines Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/gi-insights/the-new-gerd-guidelines/3834/

More information

GERD assessment including ph metry predicts a high response rate to PPI standard therapy

GERD assessment including ph metry predicts a high response rate to PPI standard therapy Kandulski et al. BMC Gastroenterology 2013, 13:12 RESEARCH ARTICLE Open Access GERD assessment including ph metry predicts a high response rate to PPI standard therapy Arne Kandulski 1, Ulrich Peitz 1,2,

More information

GERD is a condition which develops when the reflux of stomach contents causes troublesome symptoms and/or complications

GERD is a condition which develops when the reflux of stomach contents causes troublesome symptoms and/or complications GERD is a condition which develops when the reflux of stomach contents causes troublesome symptoms and/or complications Esophageal Syndromes Extra - esophageal Syndromes Symptomatic Syndromes Typical reflux

More information

Review article: pharmacology of esomeprazole and comparisons with omeprazole

Review article: pharmacology of esomeprazole and comparisons with omeprazole Aliment Pharmacol Ther 2003; 17 (Suppl. 1): 5 9. Review article: pharmacology of esomeprazole and comparisons with omeprazole J. DENT Department of Gastroenterology, Hepatology and General Medicine, Royal

More information

Disclosures. Gastroesophageal Reflux Disease. Gastroesophageal Reflux Disease

Disclosures. Gastroesophageal Reflux Disease. Gastroesophageal Reflux Disease Kunal Jajoo, MD Brigham and Women s Hospital July 2012 Disclosures Spouse is a physician employed by Boston Scientific Corporation The content of this lecture equitably discusses products of multiple companies

More information

Treatment Options for GERD or Acid Reflux Disease A Review of the Research for Adults

Treatment Options for GERD or Acid Reflux Disease A Review of the Research for Adults Treatment Options for GERD or Acid Reflux Disease A Review of the Research for Adults hur till återvinna från prostataoperation Is This Information Right for Me? Yes, if: A doctor said that you have gastroesophageal

More information

Esophageal Disorders. Learning Objectives. Introduction. Gastroesophageal Reflux Disease. Reza Shaker, MD, and Benson T.

Esophageal Disorders. Learning Objectives. Introduction. Gastroesophageal Reflux Disease. Reza Shaker, MD, and Benson T. Esophageal Disorders Reza Shaker, MD, and Benson T. Massey, MD, FACP Learning Objectives AFTER COMPLETING THIS CHAPTER, THE LEARNER SHOULD BE ABLE TO: 1. Recognize the typical and atypical presentations

More information